Drug Profile
HGP 31
Latest Information Update: 08 Feb 2008
Price :
$50
*
At a glance
- Originator HG Pars
- Class Antibacterials; Beta-lactams
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 14 Jul 1998 No-Development-Reported for Bacterial infections in USA (Unknown route)
- 04 May 1995 New profile